Fortis Gurugram Sets Benchmark in Hematologic Cancer Treatment with ET Health Conclave 2025 Award

Fortis Hospital, Gurugram has been recognized with the "Excellence in Hematologic Cancer Care & Bone Marrow Transplant" award at the prestigious ET Health Conclave 2025, an initiative by the Times of India.

This recognition is a proud moment for the entire Fortis family and underscores our commitment to delivering cutting-edge, compassionate cancer care.

The award was presented to Dr. Rahul Bhargava, Principal Director & Chief – Haematology, Hemato-Oncology, BMT & CAR-T Cell, in acknowledgment of his remarkable contributions and pioneering work in the field of blood cancers and bone marrow transplantation.

We congratulate Dr. Bhargava and the entire oncology team at Fortis Gurugram for their relentless pursuit of clinical excellence, research innovation, and patient-centric care